Encorafenib, Binimetinib, and Cetuximab in <i>BRAF</i> V600E–Mutated Colorectal CancerScott Kopetz, Josep Tabernero, Fotios Loupakis et al.|New England Journal of Medicine|2019Cited by 1.5k
Pervasive chromosomal instability and karyotype order in tumour evolutionThomas B.K. Watkins, Mariam Jamal‐Hanjani, Emilia L. Lim et al.|Nature|2020Cited by 401
Combination of the STING Agonist MIW815 (ADU-S100) and PD-1 Inhibitor Spartalizumab in Advanced/Metastatic Solid Tumors or Lymphomas: An Open-Label, Multicenter, Phase Ib StudyFunda Meric‐Bernstam, Shahneen Sandhu, Randy F. Sweis et al.|Clinical Cancer Research|2022Cited by 226
Phase Ib study of MIW815 (ADU-S100) in combination with spartalizumab (PDR001) in patients (pts) with advanced/metastatic solid tumors or lymphomas.Funda Meric‐Bernstam, Jason J. Luke, Shahneen Sandhu et al.|Journal of Clinical Oncology|2019Cited by 192